{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:54:12Z","timestamp":1793760852756,"version":"4.6.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.urology.2020.04.109","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T21:33:33Z","timestamp":1589837613000},"page":"81-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Racial and Socioeconomic Factors Influence Utilization of Advanced Therapies in Commercially Insured OAB Patients: An Analysis of Over 800,000 OAB Patients"],"prefix":"10.1016","volume":"142","author":[{"given":"Raveen","family":"Syan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyuan A.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekene A.","family":"Enemchukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2020.04.109_bib0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardization of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurology Urodyn"},{"key":"10.1016\/j.urology.2020.04.109_bib0002","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2020.04.109_bib0003","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2020.04.109_bib0004","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2020.04.109_bib0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/nau.22295","article-title":"The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial\/ethnic group and age: results from OAB-POLL","volume":"32","author":"Coyne","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2020.04.109_bib0006","first-page":"572","article-title":"Prevalence of urinary incontinence symptoms among black, white, and Hispanic women","volume":"99","author":"Sze","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.urology.2020.04.109_bib0007","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/aje\/kwm356","article-title":"Prevalence of and risk factors for urine leakage in a racially and ethnically diverse population of adults: the Boston Area Community Health (BACH) Survey","volume":"167","author":"Tennstedt","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urology.2020.04.109_bib0008","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.urology.2011.09.010","article-title":"Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study","volume":"79","author":"Coyne","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.04.109_bib0009","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-5347(05)00039-X","article-title":"Differences in prevalence of urinary incontinence by race\/ethnicity","volume":"175","author":"Thom","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.04.109_bib0010","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.ajog.2006.03.052","article-title":"Urinary incontinence and pelvic floor dysfunction in Asian-American women","volume":"195","author":"Huang","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.urology.2020.04.109_bib0011","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajog.2007.02.051","article-title":"Seeking healthcare for pelvic floor disorders: a population-based study","volume":"197","author":"Morrill","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.urology.2020.04.109_bib0012","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/SPV.0000000000000100","article-title":"Barriers to urinary incontinence care seeking in White, Black, and Latina women","volume":"21","author":"Willis-Gray","year":"2015","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.urology.2020.04.109_bib0013","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1158\/1055-9965.EPI-14-0487","article-title":"Patient and provider characteristics associated with colorectal, breast, and cervical cancer screening among Asian Americans","volume":"23","author":"Thompson","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6 Suppl","key":"10.1016\/j.urology.2020.04.109_bib0014","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.juro.2012.09.079","article-title":"American Urological Association, Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline","volume":"188","author":"Gormley","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.04.109_bib0015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/JU.0000000000000309","article-title":"Diagnosis and treatment of overactive bladder (Non-Neurogenic) in adults: AUA\/SUFU Guideline Amendment 2019","volume":"202","author":"Lightner","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.04.109_bib0016","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.juro.2015.03.111","article-title":"Disparities in the use of sacral neuromodulation among medicare beneficiaries","volume":"194","author":"Laudano","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.04.109_bib0017","series-title":"ICS 2018 Annual Meeting. Philadelphia, PA. Abstract # 146","article-title":"Trends in the management of overactive bladder in the United States from 2003-2015","author":"Syan","year":"2018"},{"key":"10.1016\/j.urology.2020.04.109_bib0018","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.juro.2010.10.060","article-title":"National trends in the usage and success of sacral nerve test stimulation","volume":"185","author":"Cameron","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.04.109_bib0019","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.juro.2007.01.035","article-title":"Racial disparities in the surgical management of stress incontinence among female medicare beneficiaries","volume":"177","author":"Anger","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.04.109_bib0020","doi-asserted-by":"crossref","first-page":"266.e1","DOI":"10.1016\/j.ajog.2015.08.072","article-title":"Bridging the gap: determinants of undiagnosed or untreated urinary incontinence in women","volume":"214","author":"Duralde","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.urology.2020.04.109_bib0021","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.urology.2015.09.025","article-title":"Real-world patterns of care for the overactive bladder syndrome in the United States","volume":"87","author":"Goldman","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.04.109_bib0022","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.urology.2018.12.021","article-title":"Prevalence, risk factors, and treatment for overactive bladder in a racially diverse population","volume":"126","author":"Mckellar","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.04.109_bib0023","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.juro.2017.09.102","article-title":"Use of third line therapy for overactive bladder in a practice with multiple subspecialty providers-are we doing enough?","author":"Moskowitz","year":"2018","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520305574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520305574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:08:26Z","timestamp":1758766106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429520305574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":23,"alternative-id":["S0090429520305574"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2020.04.109","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and Socioeconomic Factors Influence Utilization of Advanced Therapies in Commercially Insured OAB Patients: An Analysis of Over 800,000 OAB Patients","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2020.04.109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}